Cargando…
Overview of a chemoresponse assay in ovarian cancer
The objective of this review is to summarize recent scientific and medical literature regarding chemoresponse assays or chemotherapy sensitivity and resistance assays (CSRAs), specifically as applied to epithelial ovarian cancer. A total of sixty-seven articles, identified through PubMed using the k...
Autores principales: | Grendys, E. C., Fiorica, J. V., Orr, J. W., Holloway, R., Wang, D., Tian, C., Chan, J. K., Herzog, T. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139589/ https://www.ncbi.nlm.nih.gov/pubmed/24986099 http://dx.doi.org/10.1007/s12094-014-1192-8 |
Ejemplares similares
-
Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers
por: Conde, E., et al.
Publicado: (2013) -
GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
por: González Martín, A., et al.
Publicado: (2013) -
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours
por: Dumoulin, Daphne W., et al.
Publicado: (2023) -
Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer
por: Sastre, J., et al.
Publicado: (2014) -
Comment on: ‘Evaluation of chemoresponse assays as predictive markers'
por: Tian, C, et al.
Publicado: (2015)